- GSK improves position in emerging markets with Egyptian buy
- GSK acquires Bristol-Myers Squibb Pakistan for $36.5mm
- BMS sells 15% of Mead through IPO that nets $684mm
- Sanofi bids to take the rest of Zentiva
- Sanofi acquires Brazilian generics firm Medley for €500mm
- Sanofi-Aventis buys Kendrick Farmaceutica
- Sanofi-Synthélabo closes takeover of Aventis
- GSK partners with Aspen/Strides JV in emerging markets
- GSK may buy minority stake in African pharmaco Aspen
- GSK buys UCB's emerging markets businesses for €515mm
- GSK to sell Dr. Reddy's products in emerging markets
- Dr. Reddy's buys betapharm for €480mm in cash
- Pfizer acquires Wyeth in $67bn deal
- Pfizer licenses generics portfolio from Aurobindo Pharma
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.